Logo image of ALT

ALTIMMUNE INC (ALT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALT - US02155H2004 - Common Stock

5.17 USD
0 (0%)
Last: 11/28/2025, 12:35:08 PM
Fundamental Rating

3

ALT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 533 industry peers in the Biotechnology industry. The financial health of ALT is average, but there are quite some concerns on its profitability. ALT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALT has reported negative net income.
In the past year ALT has reported a negative cash flow from operations.
ALT had negative earnings in each of the past 5 years.
ALT had a negative operating cash flow in each of the past 5 years.
ALT Yearly Net Income VS EBIT VS OCF VS FCFALT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

ALT has a Return On Assets of -38.41%. This is in the better half of the industry: ALT outperforms 61.16% of its industry peers.
The Return On Equity of ALT (-45.21%) is better than 68.67% of its industry peers.
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROIC N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ALT Yearly ROA, ROE, ROICALT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

ALT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALT Yearly Profit, Operating, Gross MarginsALT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K

More info and screens

5

2. Health

2.1 Basic Checks

ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALT has more shares outstanding
There is no outstanding debt for ALT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALT Yearly Shares OutstandingALT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALT Yearly Total Debt VS Total AssetsALT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.10 indicates that ALT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.10, ALT is in the better half of the industry, outperforming 72.23% of the companies in the same industry.
ALT has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
ALT's Debt to Equity ratio of 0.08 is on the low side compared to the rest of the industry. ALT is outperformed by 61.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 4.1
ROIC/WACCN/A
WACC8.64%
ALT Yearly LT Debt VS Equity VS FCFALT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

ALT has a Current Ratio of 17.18. This indicates that ALT is financially healthy and has no problem in meeting its short term obligations.
ALT has a Current ratio of 17.18. This is amongst the best in the industry. ALT outperforms 94.00% of its industry peers.
ALT has a Quick Ratio of 17.18. This indicates that ALT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 17.18, ALT belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.18
Quick Ratio 17.18
ALT Yearly Current Assets VS Current LiabilitesALT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.15% over the past year.
The Revenue for ALT has decreased by -61.54% in the past year. This is quite bad
ALT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -67.82% yearly.
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%

3.2 Future

The Earnings Per Share is expected to grow by 39.39% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALT will show a very strong growth in Revenue. The Revenue will grow by 889.71% on average per year.
EPS Next Y16.26%
EPS Next 2Y-0.21%
EPS Next 3Y6%
EPS Next 5Y39.39%
Revenue Next Year12.6%
Revenue Next 2Y-24.37%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALT Yearly Revenue VS EstimatesALT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 500M 1B 1.5B
ALT Yearly EPS VS EstimatesALT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 20 -20 -40 -60 -80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALT Price Earnings VS Forward Price EarningsALT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALT Per share dataALT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.21%
EPS Next 3Y6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTIMMUNE INC

NASDAQ:ALT (11/28/2025, 12:35:08 PM)

5.17

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners43.36%
Inst Owner Change6.65%
Ins Owners0.77%
Ins Owner Change0.33%
Market Cap456.30M
Revenue(TTM)20.00K
Net Income(TTM)-83.92M
Analysts78.57
Price Target18.93 (266.15%)
Short Float %24.87%
Short Ratio7.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.69%
Min EPS beat(2)17.24%
Max EPS beat(2)26.14%
EPS beat(4)4
Avg EPS beat(4)18.17%
Min EPS beat(4)0.21%
Max EPS beat(4)29.11%
EPS beat(8)7
Avg EPS beat(8)14.31%
EPS beat(12)11
Avg EPS beat(12)15.65%
EPS beat(16)15
Avg EPS beat(16)15.29%
Revenue beat(2)2
Avg Revenue beat(2)296.04%
Min Revenue beat(2)296.04%
Max Revenue beat(2)296.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.6%
PT rev (3m)0.6%
EPS NQ rev (1m)20.53%
EPS NQ rev (3m)-168.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-18.17%
Revenue NY rev (3m)50.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22815.21
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 2.46
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0
BVpS2.1
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.18
Quick Ratio 17.18
Altman-Z 4.1
F-Score3
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
EPS Next Y16.26%
EPS Next 2Y-0.21%
EPS Next 3Y6%
EPS Next 5Y39.39%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%
Revenue Next Year12.6%
Revenue Next 2Y-24.37%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%
EBIT growth 1Y9.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.71%
EBIT Next 3Y-16.88%
EBIT Next 5Y13.54%
FCF growth 1Y13.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.37%
OCF growth 3YN/A
OCF growth 5YN/A

ALTIMMUNE INC / ALT FAQ

What is the ChartMill fundamental rating of ALTIMMUNE INC (ALT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALT.


Can you provide the valuation status for ALTIMMUNE INC?

ChartMill assigns a valuation rating of 0 / 10 to ALTIMMUNE INC (ALT). This can be considered as Overvalued.


Can you provide the profitability details for ALTIMMUNE INC?

ALTIMMUNE INC (ALT) has a profitability rating of 1 / 10.


Can you provide the financial health for ALT stock?

The financial health rating of ALTIMMUNE INC (ALT) is 5 / 10.


What is the earnings growth outlook for ALTIMMUNE INC?

The Earnings per Share (EPS) of ALTIMMUNE INC (ALT) is expected to grow by 16.26% in the next year.